Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy

(2019). Comparison of extended to standard half-life recombinant factor VIII therapy in patients with hemophilia A on prophylactic therapy. Journal of Drug Assessment: Vol. 8, Abstracts from the Seventh Annual National Association of Specialty Pharmacy (NASP) Meeting, pp. 46-47.